American Portfolios Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

American Portfolios Advisors’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$101K	Sell	1,500 -4,164	-74%	-$307K	﹤0.01%	1359
2022 Q2	$435K	Buy	5,664 +2,952	+109%	+$230K	0.02%	722
2022 Q1	$216K	Buy	+2,712	New	+$208K	0.01%	1125
2021 Q3	–	Sell	-33	Closed	-$2.41K	–	3524
2021 Q2	$2.41K	Hold	33	–	–	﹤0.01%	3101
2021 Q1	$2.28K	Buy	+33	New	+$2.27K	﹤0.01%	2959

Other funds holding PPH

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LJAC

L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return

American Portfolios Advisors's PPH Position: Q3 2022 in Review

American Portfolios Advisors reduced its VanEck Pharmaceutical ETF (PPH) stake by 74% in Q3 2022, selling an estimated $307K and leaving 1,500 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #1359.

American Portfolios Advisors first reported a position in PPH in Q1 2021 and has held it in 5 quarters since. The position peaked at $435K in Q2 2022. 86 funds tracked by Wall St. Rank hold PPH as of Q3 2022.

American Portfolios Advisors held 1,500 shares of VanEck Pharmaceutical ETF worth $101K as of Q3 2022.
American Portfolios Advisors sold 4,164 VanEck Pharmaceutical ETF shares in Q3 2022, an estimated $307K.
VanEck Pharmaceutical ETF made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1359 holding.
American Portfolios Advisors first reported a position in VanEck Pharmaceutical ETF in Q1 2021 and has held it in 5 quarters since.
American Portfolios Advisors's VanEck Pharmaceutical ETF position peaked at $435K in Q2 2022.
86 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.